330 related articles for article (PubMed ID: 26259851)
1. Role of cerebellar adrenomedullin in blood pressure regulation.
Figueira L; Israel A
Neuropeptides; 2015 Dec; 54():59-66. PubMed ID: 26259851
[TBL] [Abstract][Full Text] [Related]
2. Effect of Valsartan on Cerebellar Adrenomedullin System Dysregulation During Hypertension.
Figueira L; Israel A
Cerebellum; 2017 Feb; 16(1):132-141. PubMed ID: 27108271
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar Adrenomedullinergic System. Role in Cardiovascular Regulation.
Figueira L; Israel A
Adv Exp Med Biol; 2017; 956():541-560. PubMed ID: 27614623
[TBL] [Abstract][Full Text] [Related]
4. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
[TBL] [Abstract][Full Text] [Related]
5. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
6. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
Zhou YB; Sun HJ; Chen D; Liu TY; Han Y; Wang JJ; Tang CS; Kang YM; Zhu GQ
Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Cerebellar Adrenomedullin Signaling During Hypertension.
Figueira L; Israel A
J Mol Neurosci; 2017 Aug; 62(3-4):281-290. PubMed ID: 28653133
[TBL] [Abstract][Full Text] [Related]
9. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.
Tadokoro K; Nishikimi T; Mori Y; Wang X; Akimoto K; Matsuoka H
Regul Pept; 2003 Apr; 112(1-3):71-8. PubMed ID: 12667627
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
Wang X; Nishikimi T; Akimoto K; Tadokoro K; Mori Y; Minamino N
J Hypertens; 2003 Jun; 21(6):1171-81. PubMed ID: 12777955
[TBL] [Abstract][Full Text] [Related]
11. The myocardial response to adrenomedullin involves increased cAMP generation as well as augmented Akt phosphorylation.
Pan CS; Jin SJ; Cao CQ; Zhao J; Zhang J; Wang X; Tang CS; Qi YF
Peptides; 2007 Apr; 28(4):900-9. PubMed ID: 17306419
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin and angiotensin II signaling pathways involved in the effects on cerebellar antioxidant enzymes activity.
Leticia F; Anita I
Brain Res Bull; 2017 Jan; 128():83-91. PubMed ID: 27919636
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cerebellar adrenomedullin during acute stress].
Figueira L; Israel A
Invest Clin; 2016 Sep; 57(3):280-92. PubMed ID: 29938483
[TBL] [Abstract][Full Text] [Related]
14. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin.
Fukai N; Shichiri M; Ozawa N; Matsushita M; Hirata Y
Endocrinology; 2003 Feb; 144(2):447-53. PubMed ID: 12538603
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3.
Totsune K; Takahashi K; Mackenzie HS; Arihara Z; Satoh F; Sone M; Murakami O; Ito S; Brenner BM; Mouri T
Peptides; 2001 Nov; 22(11):1933-7. PubMed ID: 11754984
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
19. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.
Hay DL; Howitt SG; Conner AC; Schindler M; Smith DM; Poyner DR
Br J Pharmacol; 2003 Oct; 140(3):477-86. PubMed ID: 12970090
[TBL] [Abstract][Full Text] [Related]
20. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
